Cambridge Investment Research Advisors’s Invesco S&P MidCap 400 Pure Value ETF RFV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Sell
14,818
-2,030
-12% -$283K ﹤0.01% 1643
2026
Q1
$2.19M Sell
16,848
-2,913
-15% -$388K 0.01% 1521
2025
Q4
$2.52M Sell
19,761
-981
-5% -$125K 0.01% 1344
2025
Q3
$2.66M Sell
20,742
-197
-0.9% -$25.1K 0.01% 1291
2025
Q2
$2.53M Sell
20,939
-1,626
-7% -$185K 0.01% 1253
2025
Q1
$2.58M Sell
22,565
-891
-4% -$108K 0.01% 1191
2024
Q4
$2.85M Buy
23,456
+2,089
+10% +$257K 0.01% 1124
2024
Q3
$2.53M Sell
21,367
-4,260
-17% -$487K 0.01% 1176
2024
Q2
$2.86M Sell
25,627
-6,443
-20% -$732K 0.01% 1054
2024
Q1
$3.83M Buy
32,070
+3,009
+10% +$339K 0.01% 903
2023
Q4
$3.38M Sell
29,061
-7,503
-21% -$766K 0.01% 899
2023
Q3
$3.6M Buy
36,564
+6,630
+22% +$686K 0.02% 825
2023
Q2
$3.1M Buy
29,934
+2,430
+9% +$230K 0.01% 903
2023
Q1
$2.59M Sell
27,504
-265
-1% -$26.3K 0.01% 988
2022
Q4
$2.52M Buy
27,769
+13,859
+100% +$1.26M 0.01% 958
2022
Q3
$1.11M Buy
13,910
+208
+2% +$18.2K 0.01% 1403
2022
Q2
$1.14M Sell
13,702
-20
-0.1% -$1.81K 0.01% 1387
2022
Q1
$1.31M Buy
13,722
+1,758
+15% +$168K 0.01% 1392
2021
Q4
$1.16M Sell
11,964
-208
-2% -$19.8K 0.01% 1474
2021
Q3
$1.11M Buy
12,172
+6,856
+129% +$631K 0.01% 1444
2021
Q2
$489K Sell
5,316
-9,622
-64% -$909K ﹤0.01% 2080
2021
Q1
$1.35M Buy
+14,938
New +$1.24M 0.01% 1235
2020
Q1
Sell
-11,715
Closed -$808K 2439
2019
Q4
$808K Sell
11,715
-1,155
-9% -$77.2K 0.01% 1280
2019
Q3
$821K Sell
12,870
-3,410
-21% -$215K 0.01% 1193
2019
Q2
$1.09M Sell
16,280
-204
-1% -$13.5K 0.01% 982
2019
Q1
$1.09M Buy
16,484
+113
+0.7% +$7.4K 0.01% 988
2018
Q4
$919K Sell
16,371
-1,581
-9% -$102K 0.01% 977
2018
Q3
$1.29M Sell
17,952
-362
-2% -$26K 0.01% 888
2018
Q2
$1.29M Sell
18,314
-126
-0.7% -$8.67K 0.01% 848
2018
Q1
$1.22M Sell
18,440
-1,369
-7% -$94.5K 0.01% 842
2017
Q4
$1.38M Buy
19,809
+995
+5% +$66.4K 0.02% 750
2017
Q3
$1.22M Sell
18,814
-2,866
-13% -$180K 0.02% 752
2017
Q2
$1.37M Sell
21,680
-1,148
-5% -$71.1K 0.02% 661
2017
Q1
$1.42M Sell
22,828
-184
-0.8% -$11.5K 0.02% 585
2016
Q4
$1.42M Buy
23,012
+1,779
+8% +$104K 0.03% 539
2016
Q3
$1.18M Buy
21,233
+986
+5% +$53.7K 0.02% 610
2016
Q2
$1.04M Buy
20,247
+1,178
+6% +$60.6K 0.02% 592
2016
Q1
$971K Buy
19,069
+11,578
+155% +$527K 0.02% 585
2015
Q4
$357K Buy
7,491
+2,562
+52% +$129K 0.01% 1040
2015
Q3
$236K Buy
4,929
+1,219
+33% +$62.2K 0.01% 1162
2015
Q2
$202K Sell
3,710
-894
-19% -$50K 0.01% 1283
2015
Q1
$252K Buy
4,604
+268
+6% +$14.3K 0.01% 1131
2014
Q4
$236K Buy
+4,336
New +$227K 0.01% 1129
2013
Q3
Sell
-4,709
Closed -$204K 1230
2013
Q2
$204K Buy
+4,709
New +$200K 0.01% 951

Other funds holding RFV

Cambridge Investment Research Advisors's RFV Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Invesco S&P MidCap 400 Pure Value ETF (RFV) stake by 12% in Q2 2026, selling an estimated $283K and leaving 14,818 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1643.

Cambridge Investment Research Advisors first reported a position in RFV in Q2 2013 and has held it in 44 quarters since. The position peaked at $3.83M in Q1 2024. 35 funds tracked by Wall St. Rank hold RFV as of Q2 2026.

  • Cambridge Investment Research Advisors held 14,818 shares of Invesco S&P MidCap 400 Pure Value ETF worth $2.12M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 2,030 Invesco S&P MidCap 400 Pure Value ETF shares in Q2 2026, an estimated $283K.
  • Invesco S&P MidCap 400 Pure Value ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1643 holding.
  • Cambridge Investment Research Advisors first reported a position in Invesco S&P MidCap 400 Pure Value ETF in Q2 2013 and has held it in 44 quarters since.
  • Cambridge Investment Research Advisors's Invesco S&P MidCap 400 Pure Value ETF position peaked at $3.83M in Q1 2024.
  • 35 funds tracked by Wall St. Rank held Invesco S&P MidCap 400 Pure Value ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.